MFDS — authorised 24 April 2008
- Marketing authorisation holder: SALIX PHARMS
- Status: likely_approved
🇰🇷 Relistor in South Korea
MFDS authorised Relistor on 24 April 2008
Marketing authorisation
Relistor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in South Korea
Frequently asked questions
Is Relistor approved in South Korea?
Yes. MFDS authorised it on 24 April 2008.
Who is the marketing authorisation holder for Relistor in South Korea?
SALIX PHARMS holds the South Korean marketing authorisation.